» Articles » PMID: 37646666

Survival Disparities Between Children and Adolescents and Young Adults for the Major Subtypes of Non-Hodgkin Lymphoma in the Netherlands: a Large Population-based Study

Citing Articles

What can we learn from cancer registries?.

Burkhardt B Haematologica. 2023; 109(3):716-717.

PMID: 37916385 PMC: 10905063. DOI: 10.3324/haematol.2023.284104.

References
1.
Minard-Colin V, Auperin A, Pillon M, Burke G, Barkauskas D, Wheatley K . Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children. N Engl J Med. 2020; 382(23):2207-2219. PMC: 7720281. DOI: 10.1056/NEJMoa1915315. View

2.
Alvarez E, Le T, Kahn J, Winestone L, Li Q, Keegan T . Comorbidities and socioeconomic status are predictors of survival in children and young adults with Burkitt lymphoma. Leuk Lymphoma. 2021; 62(11):2804-2807. DOI: 10.1080/10428194.2021.1932873. View

3.
Sandlund J, Martin M . Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum. Hematology Am Soc Hematol Educ Program. 2016; 2016(1):589-597. PMC: 6142492. DOI: 10.1182/asheducation-2016.1.589. View

4.
Abrahao R, Ribeiro R, Lichtensztajn D, Rosenberg A, Keegan T . Survival after diffuse large B-cell lymphoma among children, adolescents, and young adults in California, 2001-2014: A population-based study. Pediatr Blood Cancer. 2018; 66(4):e27559. PMC: 9423938. DOI: 10.1002/pbc.27559. View

5.
Cairo M, Beishuizen A . Childhood, adolescent and young adult non-Hodgkin lymphoma: current perspectives. Br J Haematol. 2019; 185(6):1021-1042. PMC: 6897376. DOI: 10.1111/bjh.15764. View